🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot phase IIb trial studies how well pembrolizumab and CXCR4 antagon...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2016-12-01
Trial ID
NCT02907099
Treatments Being Tested
The purpose of this study is to determine whether BL-8040 is safe, tolerabl...
Status
Completed
Location
Hadassah Clinical Research Center
Start Date
2014-08
Trial ID
NCT02073019
This phase IV trial compares the effect of premedication regimens with meth...
Status
Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2025-09-24
Trial ID
NCT07101445
A total of 122 subjects were randomized into the study and investigated in ...
Status
Active Not Recruiting
Location
UCLA Medical Center
Start Date
2018-03-23
Trial ID
NCT03246529
Treatments Being Tested
The study will assess the corrected QT (QTc) effects (electrocardiogram \[E...
Status
Completed
Location
Celerion
Start Date
2021-06-11
Trial ID
NCT05293171
The outcome of patients with relapsed or refractory adult T-acute lymphobla...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2016-12-02
Trial ID
NCT02763384
Treatments Being Tested
The purpose of this study is to determine if combination treatment with cem...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2020-11-09
Trial ID
NCT04543071
Treatments Being Tested
Hematopoietic stem cell (HSC)-based gene therapies now offer curative poten...
Status
Completed
Location
Washington University School of Medicine
Start Date
2023-07-07
Trial ID
NCT05618301
Treatments Being Tested
This is a randomized, double-blinded, placebo-controlled, multi-center phas...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-12-01
Trial ID
NCT06514508
Treatments Being Tested